Release 5 Preview #3

This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationdispense0317

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Encounter, Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationDispense.

Generated Narrative

id: meddisp0317

status: stopped

medication:

subject: Donald Duck . Generated Summary: id: pat1; Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male;

Performers

-Actor
*Generated Summary: id: f006; id: 937223645 (OFFICIAL), id: 134IDY41W988 (USUAL); Rob van den Berk (OFFICIAL); ph: 0205569288(WORK), R.A.vandenberk@bmc.nl(WORK), fax: 0205664987(WORK); gender: male; birthDate: 1975-12-07

authorizingPrescription: Generated Summary: id: medrx0316; id: 12345689 (OFFICIAL); status: completed; intent: order; #med0306; authoredOn: 2015-01-15; instantiatesUri: http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf;

type: Trial Fill

quantity: 3 415818005

daysSupply: 1 Day

whenPrepared: 25/06/2015 12:13:00 PM

whenHandedOver: 26/06/2015 12:13:00 PM

dosageInstruction:

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.